Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Quote by Warren Buffet

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Mar 06, 2023 2:12pm

238 Views

Post# 35321873

RE:Quote by Warren Buffet

For those that are familiar with such process from the industry, negociations for a jv will take few months and that's the reasons why TLT management mentioned:

"plan to iniatiate discussion in 2023/2024 with large pharmaceutical companies for the NMIBC treatment".

So those that think a jv is imminent are in for a deception as such process involves the following steps:

- sending portfolio profile to many urology invested pharmas
- allow them to assess our platform potential versus theirs and their patents portfolio
- analyze offers received
- engage in back and forth official discussions regarding those offers
- evaluate best offers, rechallenge some interested parties
- have legals finalize the jv
- make the jv a formal deal